Sesen Bio, Inc. SESN Balance Sheet

Sesen bio, inc. (SESN)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13
Assets
Current assets:
Cash and cash equivalents
42,500	48,121	57,900	64,931	42,437	50,422	57,856	62,961	19,688	14,680	11,338	15,751	20,268	25,342	30,716	8,484	13,419	36,079	46,362	53,494	45,549	54,059	35,943	45,031	53,964	7,942
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	94	-	-	-	-	-	94	-	-	-	-	-
Prepaid expenses and other current assets
2,420	6,326	1,547	2,598	3,014	1,334	1,529	806	638	301	770	707	712	585	952	350	387	232	653	938	495	342	348	1,002	443	88
Due from related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	50	-	-	-	-	-	-	-	-	-	-	-
Total current assets
44,883	54,447	59,412	67,529	45,451	51,756	59,385	63,767	20,326	14,981	12,108	16,458	20,980	25,927	31,812	8,834	13,806	36,311	47,015	54,432	46,138	54,401	36,291	46,033	54,407	8,030
Restricted cash
20	20	20	20	20	20	20	20	10	10	10	10	10	10	10	119	174	94	94	94	-	94	94	94	94	94
Property and equipment, net of accumulated depreciation of $789 and $758, respectively
207	238	294	376	272	321	365	421	473	522	585	632	714	796	894	314	353	407	480	580	422	486	585	682	708	759
Intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Intangible assets
46,400	46,400	46,400	46,400	46,400	46,400	46,400	46,400	46,400	46,400	46,400	60,500	60,500	60,500	36,200	-	-	-	-	-	-	-	-	-	-	-
Goodwill
13,100	13,100	13,064	13,064	13,064	13,064	13,064	13,064	13,064	13,064	13,064	17,371	16,864	16,864	10,312	-	-	0	-	-	-	-	-	-	-	-
Other assets
91	196	208	223	232	0	61	41	19	120	101	77	-	0	350	0	0	13	14	16	18	19	11	15	18	2,354
Total Assets
104,665	114,365	119,398	127,612	105,439	111,561	119,295	123,713	80,292	75,097	72,268	95,048	99,068	104,097	79,578	9,267	14,333	36,825	47,603	55,122	46,578	55,000	36,981	46,824	55,227	11,237
Liabilities and Stockholders’ Equity (Deficit)
Current liabilities:
Accounts payable
2,068	1,902	2,583	2,176	1,683	1,367	1,391	1,310	1,393	907	1,366	1,245	1,214	1,667	1,761	1,855	1,588	1,246	2,279	1,880	2,043	2,458	2,588	2,602	3,070	1,746
Accrued expenses
4,893	6,169	6,350	5,630	5,234	4,746	5,170	3,223	3,853	3,813	2,915	2,492	1,897	1,774	2,492	1,153	491	1,794	1,146	618	1,327	1,987	1,656	1,140	457	850
Notes payable, current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	4,134	3,711	2,523	1,010	251	1,642	1,642	1,642	1,642
Deferred revenue
-	-	-	-	-	-	-	-	-	-	0	0	0	425	1,250	0	203	406	471	451	262	506	621	643	1,134	1,115
Due to related party
-	-	-	-	-	-	-	-	-	-	123	118	115	114	697	-	-	0	-	-	-	-	-	-	-	-
Other current liabilities
405	446	159	142	136	0	-	-	-	-	-	-	-	-	65	-	-	-	-	-	-	-	-	-	-	-
Total current liabilities
7,366	8,517	9,092	7,948	7,053	6,113	6,561	4,533	5,246	4,720	4,404	3,855	3,226	3,980	6,265	3,008	2,282	7,580	7,607	5,472	4,642	5,202	6,507	6,027	6,303	5,353
Deferred tax liability
-	-	-	-	-	-	-	-	-	-	-	-	16,335	16,335	9,774	-	-	0	-	-	-	-	-	-	-	-
Contingent consideration
-	-	-	91,400	47,400	48,400	49,500	42,300	38,400	39,600	38,100	48,800	46,600	45,100	21,900	-	-	0	-	-	-	-	-	-	-	-
Deferred revenue, net of current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	45	112	223	355
Restricted stock liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	7	8	10
Notes payable, net of current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	9,763	11,023	12,171	8,990	9,749	1,645	2,055	2,466	2,876
Warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	5	-	-	-	115	-	-	-	3,219	-	-	-	-
Due to related parties, net of current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	117	-	-	-	-	-	-	-	-	-	-	-
Warrant liability
-	-	-	-	-	-	-	-	-	-	0	0	2	-	77	13	0	-	33	96	1,915	-	-	-	-	297
Deferred tax liability
12,528	12,528	12,528	12,528	12,528	12,528	12,528	12,528	12,528	12,528	12,528	16,335	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other liabilities
-	-	311	367	398	313	311	288	260	215	170	148	-	0	0	73	81	423	275	164	65	4	-	-	-	-
Total Liabilities
86,214	141,065	116,931	-	-	67,354	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Commitments and contingencies
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders’ Equity (Deficit):
Preferred stock, $0.001 par value per share; 5,000,000 shares authorized at March 31, 2020 and December 31, 2019; no shares issued and outstanding at March 31, 2020 and December 31, 2019
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0
Common stock, $0.001 par value per share; 200,000,000 shares authorized at March 31, 2020 and December 31, 2019; 109,991,553 and 106,801,409 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
110	107	101	101	77	77	77	77	43	35	25	25	25	25	24	20	20	20	20	19	18	18	16	16	16	2
Additional paid-in capital
270,301	266,717	262,337	262,107	230,487	230,154	229,585	229,239	180,109	170,330	162,825	162,564	162,243	161,963	161,201	145,420	144,726	144,126	143,518	142,380	129,222	128,558	112,373	111,544	111,027	3,260
Accumulated deficit
-252,000	-293,524	-259,971	-246,839	-192,504	-186,024	-179,267	-165,252	-156,294	-152,331	-145,784	-136,679	-129,363	-123,311	-119,780	-139,267	-132,776	-125,202	-114,873	-105,180	-98,274	-91,750	-83,611	-72,937	-64,816	-57,594
Total Stockholders’ Equity (Deficit)
18,451	-26,700	2,467	15,369	38,060	44,207	50,395	64,064	23,858	18,034	17,066	25,910	32,905	38,677	41,445	6,173	11,970	18,944	28,665	37,219	30,966	36,826	28,778	38,623	46,227	-54,332
Total Liabilities and Stockholders’ Equity (Deficit)
104,665	114,365	119,398	127,612	105,439	111,561	119,295	123,713	80,292	75,097	72,268	95,048	99,068	104,097	79,578	9,267	14,333	36,825	47,603	55,122	46,578	55,000	36,981	46,824	55,227	11,237